STI Stock Trade Intelligence
IMR

IMRICOR MEDICAL SYSTEMS INC.

Health Care · ASX:IMR
$1.45
▼ -0.34%
Market cap
$518M
Turnover
$1,233,193
Last price
$1.45
Day change
-0.34%
Announcements
19
Range, past year
Open 1.475 · Low 1.145 · Now 1.445 · High 2.250
Open IMR in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

IMR momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-10-13.
Momentum quality
31/100
Wyckoff phase
Downtrend21d
Trend stage
Breakdown
1 Day
-0.3%
1 Week
-2.4%
1 Month
-21.9%
1 Year
-0.3%
RSI
32
Avg daily range
6.0%

IMRICOR MEDICAL SYSTEMS INC. scores 31 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Downtrend, where it has been for 21 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

What stands out
  • Volume 1.6× 60-day avg
Points to watch
  • 60d drawdown -33.1%
  • High volatility (ATR 6.0%)
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

IMR announcements

Recent price-sensitive releases.
  • 2026-10-08 FDA Completes Review of Third PMA Module Progress Report
  • 2026-09-03 FDA Accepts Imricor PMA Manufacturing Module Progress Report
  • 2026-08-28 Imricor and Philips Launch Commercial iMR Lab Solution Progress Report
  • 2026-08-10 Imricor U.S. Commercial Momentum Accelerates Progress Report
  • 2026-08-10 2026 Q2 Form 10-Q Periodic Reports - Other
  • 2026-08-10 Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission Periodic Reports - Other
  • 2026-08-07 Philips Declares Compatibility with Imricor Progress Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.